Status:
COMPLETED
Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk
Lead Sponsor:
GlaxoSmithKline
Conditions:
Growth and Development
Eligibility:
All Genders
7-10 years
Phase:
NA
Brief Summary
The present study supplements iron as part of multiple micro-nutrient supplementation to demonstrate that intake of a micronutrient fortified powder in milk helps increase the uptake of key micronutri...
Eligibility Criteria
Inclusion
- Demonstrates understanding of the study and willingness to participate as evidenced by participants' parents and/or legal guardian's voluntary written informed consent as well as written assent by the participant and has received a signed and dated copy of the informed consent form as well as the assent form
- Participant belonging to middle socio-economic background as per modified Kuppuswamy scale
- Good general and mental health with, in the opinion of the investigator or medically qualified designee
- Child residing in the peri-urban areas of Bangalore city
- Child with Z-scores of: a. height for age of 0 to ≥-3; b. BMI for age of 0 to ≥-3.
Exclusion
- Children in Care (CiC)
- Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds), any of their stated ingredients or any known food allergies like peanut allergy, gluten allergy or lactose intolerance
- Participants with severe anaemia (Haemoglobin \< 8g %) as determined by laboratory results
- Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any medical disorder that would make the participant unlikely to fully complete the study or any condition that presents undue risk from the study product or procedures in the opinion of the investigator
- Recent history (3 months) of serious infections, injuries and/ or surgeries
- Children consuming iron, calcium and/or other nutritional supplements and/ or health food drinks on a regular basis (more than 3 times a week) in last 6 months prior to screening visit
- Use of any prescription medications within 15 days prior to screening and throughout the entire duration of the study
- Recent history (within the last 1 year) of alcohol or other substance abuse.
Key Trial Info
Start Date :
February 6 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT02254460
Start Date
February 6 2013
End Date
March 8 2013
Last Update
July 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Bangalore, India, 560034